ReP USP - Resultado da busca

Artigo de periodico
Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy (2022)
Gonçalves, Maynara Santana; Silva, Djúlio César Zanin da; Henrique Neto, Álvaro; Moraes, Daniela Aparecida de; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Bragagnollo, Vinícius; Azevedo, Júlia Teixeira Cottas de; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naira Zambelli ; Rodrigues, Maria Carolina de Oliveira
Source: Therapeutic Advances in Musculoskeletal Disease. Unidades: FMRP, FCFRP
Subjects: BIOMARCADORES, CÉLULAS, ENDOTÉLIO, DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maynara Santana et al. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, v. 14, p. 1- 13, 2022Tradução . . Disponível em: https://doi.org/10.1177/1759720X221084845. Acesso em: 13 nov. 2024.
APA
Gonçalves, M. S., Silva, D. C. Z. da, Henrique Neto, Á., Moraes, D. A. de, Vasconcelos, M. Y. K., Lima Júnior, J. R., et al. (2022). Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, 14, 1- 13. doi:10.1177/1759720X221084845
NLM
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1177/1759720X221084845
Vancouver
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1177/1759720X221084845
Artigo de periodico
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients (2022)
Silva, Djúlio César Zanin da; Gonçalves, Maynara Santana; Vasconcelos, Marianna Yumi Kawashima; Lima Júnior, João Rodrigues; Dias, Juliana Bernardes Elias; Moraes, Daniela A.; Covas, Dimas Tadeu; Farias, Kelen Cristina Ribeiro Malmegrim de ; Ramalho, Leandra Naíra Zambelli; Rodrigues, Maria Carolina de Oliveira
Source: Arthritis Research & Therapy. Unidades: FMRP, FCFRP
Subjects: TECIDO CONJUNTIVO, DOENÇA CRÔNICA, DOENÇAS AUTOIMUNES, FIBROBLASTOS, CÉLULAS-TRONCO, MATRIZ EXTRACELULAR, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Djúlio César Zanin da et al. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, v. 24, n. 1, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1186/s13075-022-02779-w. Acesso em: 13 nov. 2024.
APA
Silva, D. C. Z. da, Gonçalves, M. S., Vasconcelos, M. Y. K., Lima Júnior, J. R., Dias, J. B. E., Moraes, D. A., et al. (2022). Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients. Arthritis Research & Therapy, 24( 1), 1-11. doi:10.1186/s13075-022-02779-w
NLM
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Vancouver
Silva DCZ da, Gonçalves MS, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Moraes DA, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients [Internet]. Arthritis Research & Therapy. 2022 ; 24( 1): 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1186/s13075-022-02779-w
Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Subjects: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 13 nov. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Mesenchymal stromal cells in viral infections: implications for COVID-19 (2021)
Rocha, José Lucas Martins; Oliveira, Waldir César Ferreira de; Noronha, Nádia de Cássia ; Santos, Natalia Cristine Dias dos; Covas, Dimas Tadeu; Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Stem Cell Reviews and Reports. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, COVID-19, ADJUVANTES IMUNOLÓGICOS, INSUFICIÊNCIA RESPIRATÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, José Lucas Martins et al. Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, v. 17, n. 1, p. 71-93, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12015-020-10032-7. Acesso em: 13 nov. 2024.
APA
Rocha, J. L. M., Oliveira, W. C. F. de, Noronha, N. de C., Santos, N. C. D. dos, Covas, D. T., Picanço-Castro, V., et al. (2021). Mesenchymal stromal cells in viral infections: implications for COVID-19. Stem Cell Reviews and Reports, 17( 1), 71-93. doi:10.1007/s12015-020-10032-7
NLM
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Vancouver
Rocha JLM, Oliveira WCF de, Noronha N de C, Santos NCD dos, Covas DT, Picanço-Castro V, Swiech K, Farias KCRM de. Mesenchymal stromal cells in viral infections: implications for COVID-19 [Internet]. Stem Cell Reviews and Reports. 2021 ; 17( 1): 71-93.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s12015-020-10032-7
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 13 nov. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (2021)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Berzoti-Coelho, Maria Gabriela ; Pereira, Illy Enne Gomes ; Frantz, Fabiani Gai ; Souto, Elizabeth Xisto; Covas, Dimas Tadeu; Figueiredo-Pontes, Lorena Lobo de; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro ; Castro, Fabíola Attié de
Source: Frontiers in Oncology. Unidades: FCFRP, FMRP
Subjects: NEOVASCULARIZAÇÃO PATOLÓGICA, MEDULA ÓSSEA, CITOCINAS, INFLAMAÇÃO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, v. 11, p. 1-12 , 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.665037. Acesso em: 13 nov. 2024.
APA
Cominal, J. G., Cacemiro, M. da C., Berzoti-Coelho, M. G., Pereira, I. E. G., Frantz, F. G., Souto, E. X., et al. (2021). Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Frontiers in Oncology, 11, 1-12 . doi:10.3389/fonc.2021.665037
NLM
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Vancouver
Cominal JG, Cacemiro M da C, Berzoti-Coelho MG, Pereira IEG, Frantz FG, Souto EX, Covas DT, Figueiredo-Pontes LL de, Oliveira MC, Malmegrim KCR, Castro FA de. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms [Internet]. Frontiers in Oncology. 2021 ; 11 1-12 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fonc.2021.665037
Artigo de periodico
Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor (2021)
Noronha, Nadia de Cássia; Mizukami, Amanda; Orellana, Maristela Delgado; Oliveira, Maria Carolina de; Covas, Dimas Tadeu; Swiech, Kamilla; Malmegrim, Kelen Cristina Ribeiro
Source: Biochemical Engineering Journal. Unidades: FMRP, FCFRP
Subjects: CÉLULAS ESTROMAIS, ANÓXIA, REATORES BIOQUÍMICOS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nadia de Cássia et al. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, v. 168, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bej.2021.107949. Acesso em: 13 nov. 2024.
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Oliveira, M. C. de, Covas, D. T., Swiech, K., & Malmegrim, K. C. R. (2021). Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor. Biochemical Engineering Journal, 168, 1-11. doi:10.1016/j.bej.2021.107949
NLM
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Oliveira MC de, Covas DT, Swiech K, Malmegrim KCR. Hypoxia priming improves in vitro angiogenic properties of umbilical cord derived-mesenchymal stromal cells expanded in stirred-tank bioreactor [Internet]. Biochemical Engineering Journal. 2021 ; 168 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.bej.2021.107949
Monografia/livro-ed/org
Chimeric antigen receptor T Cells: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, BIOLOGIA MOLECULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cells: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 13 nov. 2024. , 2020
APA
Chimeric antigen receptor T Cells: development and production. (2020). Chimeric antigen receptor T Cells: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cells: development and production [Internet]. 2020 ;[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Monografia/livro-ed/org
Chimeric antigen receptor T Cell: development and production (2020)
Swiech, Kamilla (Editor) ; Malmegrim, Kelen Cristina Ribeiro (Editor) ; Picanço-Castro, Virgínia (Editor)
Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, RECEPTORES DE ANTÍGENOS, ANTÍGENOS, LINHAGEM CELULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chimeric antigen receptor T Cell: development and production. . New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 13 nov. 2024. , 2020
APA
Chimeric antigen receptor T Cell: development and production. (2020). Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Chimeric antigen receptor T Cell: development and production [Internet]. 2020 ;[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro-apres/pref/posf
Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] (2020)
Swiech, Kamilla ; Malmegrim, Kelen Cristina Ribeiro ; Picanço-Castro, Virgínia
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, ANTÍGENOS, RECEPTORES DE ANTÍGENOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWIECH, Kamilla e MALMEGRIM, Kelen Cristina Ribeiro e PICANÇO-CASTRO, Virgínia. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 13 nov. 2024. , 2020
APA
Swiech, K., Malmegrim, K. C. R., & Picanço-Castro, V. (2020). Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]. Chimeric antigen receptor T Cell: development and production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Swiech K, Malmegrim KCR, Picanço-Castro V. Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio] [Internet]. Chimeric antigen receptor T Cell: development and production. 2020 ;274 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro
Immunophenotypic analysis of CAR-T cells (2020)
Azevedo, Júlia Teixeira Cottas de ; Mizukami, Amanda ; Moço, Pablo Diego ; Malmegrim, Kelen Cristina Ribeiro
Source: Chimeric antigen receptor T Cell: development and production. Unidades: FCFRP, FMRP
Subjects: RECEPTORES DE ANTÍGENOS, ANTÍGENOS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Immunophenotypic analysis of CAR-T cells. Chimeric antigen receptor T Cell: development and production. Tradução . New York: Humana Press, 2020. p. 274 . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4. Acesso em: 13 nov. 2024.
APA
Azevedo, J. T. C. de, Mizukami, A., Moço, P. D., & Malmegrim, K. C. R. (2020). Immunophenotypic analysis of CAR-T cells. In Chimeric antigen receptor T Cell: development and production (p. 274 ). New York: Humana Press. doi:10.1007/978-1-0716-0146-4
NLM
Azevedo JTC de, Mizukami A, Moço PD, Malmegrim KCR. Immunophenotypic analysis of CAR-T cells [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Vancouver
Azevedo JTC de, Mizukami A, Moço PD, Malmegrim KCR. Immunophenotypic analysis of CAR-T cells [Internet]. In: Chimeric antigen receptor T Cell: development and production. New York: Humana Press; 2020. p. 274 .[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4
Parte de monografia/livro
New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement (2020)
Couri, Carlos Eduardo Barra; Farias, Kelen Cristina Ribeiro Malmegrim de ; Rodrigues, Maria Carolina de Oliveira
Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: AUTOIMUNIDADE, CÉLULAS VEGETAIS, TRANSPLANTE DE ÓRGÃOS, BIOMARCADORES, DIABETES MELLITUS, TRANSPLANTE AUTÓLOGO, IMUNOSSUPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COURI, Carlos Eduardo Barra e FARIAS, Kelen Cristina Ribeiro Malmegrim de e RODRIGUES, Maria Carolina de Oliveira. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 13 nov. 2024.
APA
Couri, C. E. B., Farias, K. C. R. M. de, & Rodrigues, M. C. de O. (2020). New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Couri CEB, Farias KCRM de, Rodrigues MC de O. New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Trabalho de evento-resumo periodico
Non-viral engineering of CAR-NK cells for cancer immunotherapy (2020)
Gomes, Kauan Ribeiro de Sena; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LINFÓCITOS, CÉLULAS, IMUNOTERAPIA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Kauan Ribeiro de Sena et al. Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.706. Acesso em: 13 nov. 2024. , 2020
APA
Gomes, K. R. de S., Silvestre, R. N., Azevedo, J. T. C. de, Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Non-viral engineering of CAR-NK cells for cancer immunotherapy. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.706
NLM
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Vancouver
Gomes KR de S, Silvestre RN, Azevedo JTC de, Swiech K, Farias KCRM de, Covas DT, Picanço-Castro V. Non-viral engineering of CAR-NK cells for cancer immunotherapy [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S420.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.706
Trabalho de evento-resumo periodico
Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
Silvestre, Renata Nacasaki; Eitler, J.; Fantacini, Daianne Maciely Carvalho ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu; Tonn, T.; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: LEUCEMIA, LINFOMA, LINFÓCITOS B, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 13 nov. 2024. , 2020
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703
Trabalho de evento-resumo periodico
Optimizing intracellular signaling domains for CAR-NK cells (2020)
Azevedo, Júlia Teixeira Cottas de; Silvestre, Renata Nacasaki; Pessoni, André Moreira ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Picanço-Castro, Virgínia
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020). Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, NEOPLASIAS, PROLIFERAÇÃO CELULAR, LEUCEMIA, LINFOMA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de et al. Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.710. Acesso em: 13 nov. 2024. , 2020
APA
Azevedo, J. T. C. de, Silvestre, R. N., Pessoni, A. M., Farias, K. C. R. M. de, Covas, D. T., & Picanço-Castro, V. (2020). Optimizing intracellular signaling domains for CAR-NK cells. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.710
NLM
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Vancouver
Azevedo JTC de, Silvestre RN, Pessoni AM, Farias KCRM de, Covas DT, Picanço-Castro V. Optimizing intracellular signaling domains for CAR-NK cells [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S422-S423.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.710
Artigo de periodico
Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives (2020)
Azevedo, Júlia Teixeira Cottas de ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Immunology Letters. Unidades: FCFRP, FMRP
Subjects: SISTEMA IMUNE, BIOMARCADORES, IMUNIDADE, ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Júlia Teixeira Cottas de e FARIAS, Kelen Cristina Ribeiro Malmegrim de. Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives. Immunology Letters, v. 224, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.imlet.2020.04.012. Acesso em: 13 nov. 2024.
APA
Azevedo, J. T. C. de, & Farias, K. C. R. M. de. (2020). Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives. Immunology Letters, 224, 1-11. doi:10.1016/j.imlet.2020.04.012
NLM
Azevedo JTC de, Farias KCRM de. Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives [Internet]. Immunology Letters. 2020 ; 224 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.imlet.2020.04.012
Vancouver
Azevedo JTC de, Farias KCRM de. Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives [Internet]. Immunology Letters. 2020 ; 224 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.imlet.2020.04.012
Artigo de periodico-carta/editorial
CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] (2020)
Arruda, Lucas Coelho Marliére; Clave, Emmanuel; Douay, Corinne; Lima Júnior, João Rodrigues; Slavov, Svetoslav Nanev; Farias, Kelen Cristina Ribeiro Malmegrim de ; Alberdi, Antônio José; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS CLONAIS, IMUNOLOGIA, CITOMEGALOVIRUS, TRANSPLANTES, CÉLULAS-TRONCO, RECEPTORES, ANTÍGENOS, VIROLOGIA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas Coelho Marliére et al. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/rheumatology/keaa001. Acesso em: 13 nov. 2024. , 2020
APA
Arruda, L. C. M., Clave, E., Douay, C., Lima Júnior, J. R., Slavov, S. N., Farias, K. C. R. M. de, et al. (2020). CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/rheumatology/keaa001
NLM
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Vancouver
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Parte de monografia/livro
Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Toubert, Antoine; Farge, Dominique; Rodrigues, Maria Carolina de Oliveira
Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, DOENÇAS AUTOIMUNES, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 13 nov. 2024.
APA
Farias, K. C. R. M. de, Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2020). Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Toubert A, Farge D, Rodrigues MC de O. Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Artigo de periodico
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies (2020)
Picanço-Castro, Virgínia; Moço, Pablo Diego; Mizukami, Amanda; Vaz, Leticia Delfini; Pereira, Marcelo de Souza Fernandes; Silvestre, Renata Nacasaki; Azevedo, Júlia Teixeira Cottas de; Bomfim, Aline de Sousa; Abreu-Neto, Mário Soares de; Farias, Kelen Cristina Ribeiro Malmegrim de ; Swiech, Kamilla ; Covas, Dimas Tadeu
Source: Hematology, Transfusion and Cell Therapy. Unidades: FCFRP, FMRP
Subjects: HEMATOLOGIA, CITOTOXICIDADE IMUNOLÓGICA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, v. 42, n. 2, p. 150-158, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.06.007. Acesso em: 13 nov. 2024.
APA
Picanço-Castro, V., Moço, P. D., Mizukami, A., Vaz, L. D., Pereira, M. de S. F., Silvestre, R. N., et al. (2020). Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies. Hematology, Transfusion and Cell Therapy, 42( 2), 150-158. doi:10.1016/j.htct.2019.06.007
NLM
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Vancouver
Picanço-Castro V, Moço PD, Mizukami A, Vaz LD, Pereira M de SF, Silvestre RN, Azevedo JTC de, Bomfim A de S, Abreu-Neto MS de, Farias KCRM de, Swiech K, Covas DT. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 2): 150-158.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2019.06.007
Trabalho de evento-resumo periodico
Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC (2020)
Noronha, Nádia de Cássia ; Mizukami, Amanda ; Orellana, M. D.; Covas, Dimas Tadeu ; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FCFRP
Subjects: ANÓXIA, CÉLULAS ESTROMAIS, ADJUVANTES IMUNOLÓGICOS, HOMEOSTASE, DOENÇAS IMUNOLÓGICAS, DOENÇAS DEGENERATIVAS, SOBREVIVÊNCIA CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORONHA, Nádia de Cássia et al. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.705. Acesso em: 13 nov. 2024. , 2020
APA
Noronha, N. de C., Mizukami, A., Orellana, M. D., Covas, D. T., Swiech, K., & Farias, K. C. R. M. de. (2020). Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.705
NLM
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705
Vancouver
Noronha N de C, Mizukami A, Orellana MD, Covas DT, Swiech K, Farias KCRM de. Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S419.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2020.10.705

USP Schools

ReP

Filtros

Document Types

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation